Aurora Cannabis Inc (ACB.TO) has seen a modest increase in its stock price this week, amid some significant developments in the company's financial performance and market presence.
This week, Aurora Cannabis Inc's stock (ACB.TO) closed at C$5.57, reflecting a daily gain of 0.36% and a weekly rise of 2.96%. Over the past month, the stock has surged by 45.81%, although it remains down 6.23% year-to-date. As the cannabis sector continues to evolve, Aurora's recent financial disclosures and market activities warrant a closer look.
Advertisement
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$357.07M
52W high
$8.75
52W low
$3.59
1W change
-13.08%
Beta
1.42
Analyst Price Targets
Based on analyst covering ACB · as of Oct 8, 2026
Wall Street analysts forecast ACB stock price to rise 42.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.66
+42.9% Upside
Previously C$5.38 on Sep 17, 2026
Current Price
C$3.96
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
53.7%
Annualized
90-Day Vol
57.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$6.67
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$5.92 | C$4.92 – C$7.13 |
| 60 trading days | C$6.29 | C$4.84 – C$8.17 |
| 90 trading days | C$6.67 | C$4.84 – C$9.20 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Aurora Cannabis is navigating a complex landscape with fluctuating stock performance influenced by its financial results and market speculation, including a potential acquisition bid. Investors should consider these dynamics as they evaluate their positions in the stock.
C$67.6 million
Aurora Cannabis reported net revenue of C$67.6 million for Q1 2027, marking a significant 17% increase in international medical cannabis revenue year-over-year.
Bull case
The recent fiscal reports show positive revenue growth, especially in international markets. The EU-GMP certification for its subsidiary enhances Aurora’s competitive edge in the global medical cannabis space, which could lead to increased market share and revenue.
Bear case
Despite the revenue growth, Aurora's profitability raises concerns due to a negative profit margin and return on equity. The unsolicited acquisition bid from Curaleaf could create uncertainty about the company's future direction and impact investor sentiment.
Recent Price Action
Advertisement
Aurora Cannabis Inc's stock (ACB.TO) closed at C$5.57, experiencing a slight increase of 0.36% on the day. Over the past week, the stock has gained 2.96%, while it has seen a remarkable 45.81% rise in the last month. However, the stock remains down 6.23% year-to-date, indicating a mixed performance overall.
Company News and Developments
Recent headlines highlight Aurora Cannabis's financial performance, with significant revenue growth reported in its fiscal results. The company announced a net revenue of C$67.6 million for Q1 2027, marking a 17% increase in international medical cannabis revenue year-over-year. Additionally, the EU-GMP certification granted to its subsidiary, Safari Flower Company, positions Aurora to expand its reach in international markets. Furthermore, an unsolicited acquisition bid from Curaleaf Holdings, offering C$4.00 per share, has added a layer of speculation regarding Aurora’s future.
Technical Picture
From a technical perspective, Aurora's stock is currently trading above its 50-day moving average of C$4.28, representing a 30.1% increase, and the 200-day moving average of C$5.06, which is 10.1% above the current price. The stock has a beta of 1.34, suggesting higher volatility compared to the market. The 52-week range for ACB.TO is C$3.59 to C$9.33, indicating it is currently trading at 34% of its range. The recent trading volume of 280,923 shares is notably below the 20-day average volume of 647,326 shares, reflecting a volume that is 0.43 times the average.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
